TickerFactsScreenerDevelopers

Anika Therapeutics, Inc. (ANIK) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2016: $24.03M2017: $27.36M2018: $31.28M2019: $28.75M2020: $61.43M2021: $64.85M2022: $40.61M2023: $38.26M2024: $43.91M2025: $49.01M$49.01M
2016Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$49.01M+11.6%
2024$43.91M+14.8%
2023$38.26M-5.8%
2022$40.61M-37.4%
2021$64.85M+5.6%
2020$61.43M+113.7%
2019$28.75M-8.1%
2018$31.28M+14.3%
2017$27.36M+13.9%
2016$24.03M—